PROBUTYRATE Trademark

Trademark Overview


On Friday, January 13, 2017, a trademark application was filed for PROBUTYRATE with the United States Patent and Trademark Office. The USPTO has given the PROBUTYRATE trademark a serial number of 87302021. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Thursday, December 19, 2024. This trademark is owned by Tesseract Medical Research, LLC. The PROBUTYRATE trademark is filed in the Pharmaceutical Products category with the following description:

Dietary supplements; nutritional supplements; medical foods, namely, medical food supplements and dietetic food supplements, both containing short-chain fatty acids in single molecule form with a release agent that enhances solubility and absorption; nutritional ingredients, namely, a blend of nutrients, namely, short-chain fatty acids in single molecule form with a release agent that ensures solubility and absorption, that are an integral component of medicals foods, for short-chain fatty acid deficiencies in individuals with Autism Spectrum Disorder; nutraceuticals for use as dietary supplements and nutritional supplements; vitamin preparations and mineral preparations to mitigate short-chain fatty acid microbiome deficiencies in individuals with Autism Spectrum Disorder; dietary supplements for restoring health in individuals with diseases, disorders, nutritional deficiencies, and adverse health conditions; therapeutic agents for human medical, medicinal, and therapeutic purposes, n...
probutyrate

General Information


Serial Number87302021
Word MarkPROBUTYRATE
Filing DateFriday, January 13, 2017
Status701 - SECTION 8 - ACCEPTED
Status DateThursday, December 19, 2024
Registration Number5414187
Registration DateTuesday, February 27, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 22, 2017

Trademark Statements


Goods and ServicesDietary supplements; nutritional supplements; medical foods, namely, medical food supplements and dietetic food supplements, both containing short-chain fatty acids in single molecule form with a release agent that enhances solubility and absorption; nutritional ingredients, namely, a blend of nutrients, namely, short-chain fatty acids in single molecule form with a release agent that ensures solubility and absorption, that are an integral component of medicals foods, for short-chain fatty acid deficiencies in individuals with Autism Spectrum Disorder; nutraceuticals for use as dietary supplements and nutritional supplements; vitamin preparations and mineral preparations to mitigate short-chain fatty acid microbiome deficiencies in individuals with Autism Spectrum Disorder; dietary supplements for restoring health in individuals with diseases, disorders, nutritional deficiencies, and adverse health conditions; therapeutic agents for human medical, medicinal, and therapeutic purposes, namely, increasing butyric acid in the gastrointestinal tract; functional nutrients containing butyric acid and acetic acid to mitigate short- chain fatty acid gut microbiome deficiencies in individuals with Autism Spectrum Disorder; pharmaceutical preparations to mitigate short-chain fatty acid gut microbiome deficiencies in individuals with Autism Spectrum Disorder; specialty nutraceuticals for the dietary management of diseases, disorders, and nutritional deficiencies, namely, short-chain fatty acid gut microbiome deficiencies in individuals with Autism Spectrum Disorder and deficiencies of butyrate in the gastrointestinal tract

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 23, 2017
Primary Code005
First Use Anywhere DateMonday, July 24, 2017
First Use In Commerce DateMonday, July 24, 2017

Trademark Owner History


Party NameTesseract Medical Research, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressNapa, CA 94558

Party NameTesseract Medical Research, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNapa, CA 94558

Party NameTesseract Medical Research, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNapa, CA 94558

Trademark Events


Event DateEvent Description
Tuesday, January 17, 2017NEW APPLICATION ENTERED
Tuesday, February 21, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 23, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 21, 2017ASSIGNED TO EXAMINER
Tuesday, February 21, 2017NON-FINAL ACTION WRITTEN
Tuesday, February 21, 2017NON-FINAL ACTION E-MAILED
Thursday, March 30, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 30, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 31, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 11, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 11, 2017NON-FINAL ACTION E-MAILED
Tuesday, April 11, 2017NON-FINAL ACTION WRITTEN
Friday, April 28, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 28, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, April 29, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 23, 2017TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, July 19, 2017ASSIGNED TO LIE
Monday, May 15, 2017FINAL REFUSAL WRITTEN
Monday, May 15, 2017FINAL REFUSAL E-MAILED
Monday, May 15, 2017NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, July 19, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 19, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 19, 2017EXAMINER'S AMENDMENT ENTERED
Wednesday, July 19, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 2, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 19, 2017EXAMINERS AMENDMENT -WRITTEN
Wednesday, July 19, 2017EXAMINERS AMENDMENT E-MAILED
Wednesday, July 19, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, July 20, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, August 22, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, December 27, 2017TEAS STATEMENT OF USE RECEIVED
Wednesday, December 27, 2017USE AMENDMENT FILED
Tuesday, February 27, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, August 22, 2017PUBLISHED FOR OPPOSITION
Tuesday, October 17, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Saturday, January 13, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, January 13, 2018STATEMENT OF USE PROCESSING COMPLETE
Wednesday, January 24, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, January 25, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 2, 2024TEAS SECTION 8 RECEIVED
Thursday, December 19, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, December 19, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED
Thursday, December 19, 2024NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Monday, February 27, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED